Gene: CPEB3
Official Full Name: cytoplasmic polyadenylation element binding protein 3provided by HGNC
Gene Summary: Enables mRNA 3'-UTR binding activity and translation factor activity, RNA binding. Involved in cellular response to amino acid stimulus and regulation of gene expression. Located in several cellular components, including cytosol; midbody; and nucleoplasm. Part of CCR4-NOT complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04187 | CPEB3 Knockout cell line (HeLa) | Human | CPEB3 | 1:3~1:6 | Negative | Online Inquiry |
KO04188 | CPEB3 Knockout cell line (HCT 116) | Human | CPEB3 | 1:2~1:4 | Negative | Online Inquiry |
KO04189 | CPEB3 Knockout cell line (HEK293) | Human | CPEB3 | 1:3~1:6 | Negative | Online Inquiry |
CPEB3 Gene Knockout Cell Lines are specialized cellular models engineered to lack the CPEB3 gene, which plays a critical role in the regulation of mRNA translation and stability in various biological processes, including neural functions and stress responses. This knockout allows researchers to dissect the intricate regulatory mechanisms that govern gene expression and protein synthesis, thereby providing powerful insights into cellular behavior and gene regulation dynamics.
The primary function of these cell lines lies in their ability to facilitate the study of CPEB3's influence on signaling pathways, cellular differentiation, and synaptic plasticity. By observing the phenotypic and molecular changes that arise from the absence of this gene, scientists can identify specific pathways that CPEB3 regulates, thereby expanding our understanding of its biological roles. The cell lines are optimized for various applications, including drug discovery, genetic studies, and the development of therapeutic strategies targeting mRNA regulation.
Scientifically, the availability of CPEB3 Gene Knockout Cell Lines holds significant importance for laboratories focused on neurobiology, cancer research, and genetic disorders. These cell lines serve as invaluable tools for elucidating the paths of mRNA regulation in both normal and pathological states, and offer a robust platform for validating potential therapeutic targets.
CPEB3 Gene Knockout Cell Lines are unique in their specificity and reliability compared to traditional genetic models, which may carry off-target effects or insufficient gene disruptions. The precision of these cell lines enhances experimental reproducibility and ensures that results are directly attributable to the absence of the CPEB3 gene. Additionally, their ease of use in standard cell culture conditions makes them accessible for both established research institutions and emerging biotech companies.
Investing in CPEB3 Gene Knockout Cell Lines is not just a means to facilitate research; it represents a commitment to advancing the frontiers of genetic understanding and therapeutic innovation. Our company is dedicated to providing high-quality biological products backed by extensive expertise in genetics and molecular biology, ensuring that researchers and clinicians have the tools necessary to conduct groundbreaking work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.